TAMPA BAY, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Energetic Harmony℠, a leader in holistic stress relief, proudly announces the…
Persica Pharmaceuticals announces positive Phase 1b clinical data for PP353, a novel, non-opioid intradiscal injection for the treatment of chronic…
March 01, 2025 12:45 ET | Source: Celldex Therapeutics, Inc. - Greatly improved patient quality of life and reduced disease…
HAMILTON, Ontario, Feb. 03, 2025 (GLOBE NEWSWIRE) -- The Chronic Pain Centre of Excellence for Canadian Veterans (CPCoE) is excited…
December 27, 2024 01:00 ET | Source: argenx SE VYVDURA® now approved for at-home self-injection in Japan for both generalized…
– ABI-4334 was well-tolerated with a favorable safety profile and half-life supporting once-daily oral dosing observed – – In the…